Crossmark

Novel insights into mechanisms of disease progression

Crossref DOI link: https://doi.org/10.1038/nrgastro.2017.181

Published Online: 2018-01-04

Published Print: 2018-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Khan, Reenam S.

Newsome, Philip N.
License Information

Text and Data Mining valid from 2018-01-04
More Information

Article History

First Online: 4 January 2018

Competing interests

: P.N.N. has served as a speaker, a consultant and an advisory board member for AbbVie, Boehringer Ingelheim, Gilead, Intercept, Janssen, Novartis, Novo Nordisk, Pharmaxis and Shire, and has received research funding from these organizations on behalf of the University of Birmingham, UK. R.S.K. has received research funding from the National Institute of Health Research.